RZLT Latest Press Releases

-- July 21, 2026 --

Rezolute to Participate in the BTIG Virtual Biotechnology Conference Globe Newswire 7:30 AM

-- June 17, 2026 --

Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society Globe Newswire 7:00 AM

-- June 4, 2026 --

Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society Globe Newswire 7:30 AM

-- June 2, 2026 --

Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism Globe Newswire 7:00 AM

-- May 12, 2026 --

Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- May 11, 2026 --

Rezolute to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM

-- May 1, 2026 --

Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting Globe Newswire 12:15 PM

-- April 24, 2026 --

Rezolute, Inc. Investigated by the Portnoy Law Firm Globe Newswire 9:00 AM

-- April 21, 2026 --

Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software